BioCryst Pharmaceuticals, Inc. (BCRX): Total Asset Value of Company
Market fluctuations in BioCryst (BCRX) share prices based on total assets are currently at 507.55. BioCryst focuses on the therapy of rare pathologies, attracting scientists through ethical values and stock options. Financial stability is based on the monetization of treatments for hereditary angioedema and patent protection. Business growth is driven by global reach and an increasing number of patients with immune disorders.
Comprehensive metric breakdowns and analytics for BioCryst Pharmaceuticals Inc (BCRX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:BCRX, biocryst.com
The indicator's dynamics are calculated inversely through return on assets (ROA), allowing the investor to track the aggregate of BioCryst (BCRX) resources and liabilities in real time between quarterly reports. An analysis of consolidated assets demonstrates the material base of BioCryst, where strong pricing power and patient loyalty to a convenient oral medication ensure a steady capital inflow to expand the business's resource potential.
Competitors of BioCryst (BCRX)
ARGX (argenx.com) - Total Business Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com (DNTH)|Pharvaris (PHVS) - Cumulative Company Assets|Aggregate Asset Value AbCellera Biologics (ABCL)|Company Total Assets TRML|Precigen Corp - Company Total Asset Base|PHAR: Aggregate Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|IMNM (Immunome Corp) - Cumulative Company Assets|Company Total Assets GOSS|Aggregate Company Assets KalVista Pharmaceuticals KALV|Total Business Assets septerna.com (SEPN)|PVLA: Company Total Assets|Company Assets Savara Inc SVRA|RIGL - Company Total Assets|ANAB - Aggregate Company Assets|Astria Therapeutics - Company Total Assets|ENGN (engene.com) - Company Total Asset Base|Aggregate Company Assets RAPT (RAPT Therapeutics)|Company Assets Aerovate|Company Total Assets ACRS (Aclaris)|Cumulative Company Assets KYTX (Kyverna Therapeutics, Inc)|Aggregate Company Assets Tiziana Life Sciences|CABA - Aggregate Asset Value|VTYX (Ventyx Biosciences, Inc.) - Cumulative Company Assets|THTX: Company Assets|Avalo Therapeutics Inc. - Aggregate Company Assets|Company Total Asset Base Eledon Pharmaceuticals, Inc|Agenus (AGEN) - Cumulative Company Assets|Aggregate Business Assets climbbio.com|Company Total Assets Zura Bio (ZURA)|Aggregate Company Assets aTyr Pharma Inc (ATYR)|Adagene Inc. - Company Total Assets|ImageneBio - Cumulative Company Assets|Aggregate Company Assets Shattuck Therapeutics (STTK)|Equillium, Inc. (EQ) - Aggregate Asset Value|Cumulative Company Assets connectbiopharm.com|IMUX (Immunic) - Total Business Assets|Aggregate Company Assets Atara Biotherapeutics, Inc. ATRA|Total Asset Value of Company InflaRx GmbH|X4 Pharmaceuticals (XFOR) - Company Total Assets|Aggregate Asset Value adicetbio.com (ACET)|Company Total Assets CELU (Celularity)|INmune Bio Inc - Company Total Assets|Aggregate Company Assets Barinthus Bio (BRNS)|KZR: Aggregate Asset Value|SABS (SAB Biotherapeutics) - Aggregate Company Assets|akaritx.com (AKTX) - Cumulative Company Assets|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Company Total Assets Q32 Bio Corp (QTTB)|GeoVax Labs Inc (GOVX) - Cumulative Company Assets|Aggregate Asset Value Edesa Biotech Corp (EDSA)|Company Total Assets IBIO|Carisma Therapeutics Inc - Company Total Asset Base|XTLB: Aggregate Company Assets|BOLT: Cumulative Company Assets|HCWB (hcwbiologics.com) - Aggregate Company Assets|Cumulative Company Assets Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech Inc.) - Cumulative Company Assets|Company Total Assets ADTX|Aggregate Company Assets GRI Bio GRI|Total Business Assets XORTX Therapeutics Inc (XRTX)|HIND: Company Total Assets|Company Assets Revelation Biosciences Corp REVB|INDP - Company Total Assets|SCNI - Aggregate Company Assets|calcimedica.com - Company Total Assets|AFMD (Affimed N.V.) - Company Total Asset Base|Aggregate Company Assets ALLK (Allakos Inc)|Company Assets HOOKIPA|Company Total Assets IGMS (IGM Biosciences, Inc.)|Cumulative Company Assets ITOS (iteostherapeutics.com)|Aggregate Company Assets Ocean Biomedical|TCBP - Aggregate Asset Value|THRD (Third Harmonic Bio, Inc) - Cumulative Company Assets